{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:13:12Z","timestamp":1789009992786,"version":"build-2803163510"},"reference-count":67,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,14]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Compared with total body irradiation (TBI) or chemotherapy, antibody-drug conjugates (ADCs) offer a more targeted and potentially less toxic method for transplantation conditioning. CD45-ADC targets a pan-leukocyte antigen expressed on hematopoietic stem and progenitor cells (HSPCs) and immune cells, offering a promising strategy for gene therapy or allogeneic transplantation. We evaluated reconstitution, clonal dynamics, immune tolerance, and toxicity after conditioning with a DGN549-C\u2013conjugated CD45-ADC followed by autologous transplantation in rhesus macaques. Two doses (0.2 and 0.3 mg\/kg) were tested, with HSPC infusion 10 days after conditioning. All animals received barcoded, copepod green fluorescent protein (CopGFP)-expressing lentivirally transduced HSPCs. Both doses resulted in profound depletion of HSPCs and expected cytopenias, with incomplete lymphocyte depletion. With 0.2 mg\/kg CD45-ADC conditioning, 2 animals showed robust multilineage engraftment with gene-modified cells and high clonal diversity, comparable with TBI. However, CopGFP+ cell levels and clonal diversity declined at 4 to 8 months, accompanied by development of anti-CopGFP antibodies, suggesting immune rejection. Incomplete T-cell depletion may have contributed. Notably, this rejection was slower and less complete than that after busulfan conditioning, suggesting partial immune tolerance. Dexamethasone treatment in 1 animal reversed rejection and stabilized CopGFP+ levels for &amp;gt;2 years. At 0.3 mg\/kg CD45-ADC, 2 animals developed severe respiratory distress 4 to 6 days after transplantation, requiring humane euthanasia, accompanied by elevated inflammatory cytokines. This severe syndrome was not seen in 9 additional animals conditioned with CD45-ADC. These findings highlight the importance of preclinical evaluation of experimental therapeutics. Combining lower-dose CD45-ADC with immune suppression may enable durable engraftment in settings of alloantigen or neoantigen expression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025018176","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T21:18:00Z","timestamp":1769548680000},"page":"2479-2494","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Clonal dynamics, tolerance, and adverse events after CD45-ADC\u2013conditioned autologous HSPC transplantation in macaques"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1369-2715","authenticated-orcid":false,"given":"Taha Bartu","family":"Hayal","sequence":"first","affiliation":[{"name":"1Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute\/National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4110-4554","authenticated-orcid":false,"given":"Diana M.","family":"Abraham","sequence":"additional","affiliation":[{"name":"1Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute\/National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6174-1609","authenticated-orcid":false,"given":"Selami","family":"Demirci","sequence":"additional","affiliation":[{"name":"2Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute\/National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Fan","sequence":"additional","affiliation":[{"name":"1Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute\/National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zhou","sequence":"additional","affiliation":[{"name":"1Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute\/National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Hyzy","sequence":"additional","affiliation":[{"name":"3Vor Bio, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9297-2855","authenticated-orcid":false,"given":"Michelle I.","family":"Lin","sequence":"additional","affiliation":[{"name":"3Vor Bio, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Linde","sequence":"additional","affiliation":[{"name":"1Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute\/National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Engels","sequence":"additional","affiliation":[{"name":"1Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute\/National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Golomb","sequence":"additional","affiliation":[{"name":"1Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute\/National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aylin","family":"Bonifacino","sequence":"additional","affiliation":[{"name":"1Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute\/National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6123-536X","authenticated-orcid":false,"given":"Luca","family":"Schifanella","sequence":"additional","affiliation":[{"name":"4Animal Models and Retroviral Vaccines Section, Basic Research Laboratory, Center for Cancer Research, National Cancer Institute\/National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"5Division of Veterinary Resources, Office of Research Services, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2150-6700","authenticated-orcid":false,"given":"Lauren R.","family":"Brinster","sequence":"additional","affiliation":[{"name":"5Division of Veterinary Resources, Office of Research Services, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9616-9414","authenticated-orcid":false,"given":"Robert V.","family":"Blair","sequence":"additional","affiliation":[{"name":"6Tulane National Primate Research Center, Tulane University, Covington, LA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecily C.","family":"Midkiff","sequence":"additional","affiliation":[{"name":"6Tulane National Primate Research Center, Tulane University, Covington, LA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2851-6589","authenticated-orcid":false,"given":"Genoveffa","family":"Franchini","sequence":"additional","affiliation":[{"name":"4Animal Models and Retroviral Vaccines Section, Basic Research Laboratory, Center for Cancer Research, National Cancer Institute\/National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6609-4896","authenticated-orcid":false,"given":"Amitinder","family":"Kaur","sequence":"additional","affiliation":[{"name":"6Tulane National Primate Research Center, Tulane University, Covington, LA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Tisdale","sequence":"additional","affiliation":[{"name":"2Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute\/National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Donahue","sequence":"additional","affiliation":[{"name":"2Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute\/National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3538-5444","authenticated-orcid":false,"given":"So Gun","family":"Hong","sequence":"additional","affiliation":[{"name":"1Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute\/National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanfeng","family":"Wu","sequence":"additional","affiliation":[{"name":"1Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute\/National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia E.","family":"Dunbar","sequence":"additional","affiliation":[{"name":"1Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute\/National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"issue":"17","key":"2026041408021560700_bib1","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"key":"2026041408021560700_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev.med.54.101601.152334","article-title":"Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system","volume":"56","author":"Shizuru","year":"2005","journal-title":"Annu Rev Med"},{"issue":"6372","key":"2026041408021560700_bib3","doi-asserted-by":"crossref","first-page":"eaan4672","DOI":"10.1126\/science.aan4672","article-title":"Gene therapy comes of age","volume":"359","author":"Dunbar","year":"2018","journal-title":"Science"},{"issue":"3","key":"2026041408021560700_bib4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood-2014-02-514778","article-title":"Conditioning regimens for hematopoietic cell transplantation: one size does not fit all","volume":"124","author":"Gyurkocza","year":"2014","journal-title":"Blood"},{"key":"2026041408021560700_bib5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.omtm.2022.12.001","article-title":"Comparison of busulfan and total body irradiation conditioning on hematopoietic clonal dynamics following lentiviral gene transfer in rhesus macaques","volume":"28","author":"Abraham","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"26","key":"2026041408021560700_bib6","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM198712243172602","article-title":"Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia","volume":"317","author":"Brochstein","year":"1987","journal-title":"N Engl J Med"},{"issue":"12","key":"2026041408021560700_bib7","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1080\/10428190412331283206","article-title":"Targeted busulfan and cyclophosphamide as compared to busulfan and TBI as preparative regimens for transplantation in patients with advanced MDS or transformation to AML","volume":"45","author":"Scott","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"2026041408021560700_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1200\/JCO.22.00767","article-title":"Busulfan plus cyclophosphamide versus total body irradiation plus cyclophosphamide for adults acute B lymphoblastic leukemia: an open-label, multicenter, phase III trial","volume":"41","author":"Zhang","year":"2023","journal-title":"J Clin Oncol"},{"issue":"11","key":"2026041408021560700_bib9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00066-009-2022-8","article-title":"Long-term renal toxicity in children following fractionated total-body irradiation (TBI) before allogeneic stem cell transplantation (SCT)","volume":"185","author":"Gerstein","year":"2009","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"2026041408021560700_bib10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0360-3016(99)00113-3","article-title":"Acute central nervous system (CNS) toxicity of total body irradiation (TBI) measured using neuropsychological testing of attention functions","volume":"44","author":"Wenz","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"22","key":"2026041408021560700_bib11","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"2026041408021560700_bib12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0360-3016(00)00669-6","article-title":"Cataract-free interval and severity of cataract after total body irradiation and bone marrow transplantation: influence of treatment parameters","volume":"48","author":"van Kempen-Harteveld","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026041408021560700_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.omtm.2019.10.010","article-title":"Immunoresponse to gene-modified hematopoietic stem cells","volume":"16","author":"Drysdale","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"2026041408021560700_bib14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and beta-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N Engl J Med"},{"issue":"5577","key":"2026041408021560700_bib15","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1126\/science.1070104","article-title":"Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning","volume":"296","author":"Aiuti","year":"2002","journal-title":"Science"},{"issue":"9","key":"2026041408021560700_bib16","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.ymthe.2019.05.022","article-title":"Busulfan combined with immunosuppression allows efficient engraftment of gene-modified cells in a rhesus macaque model","volume":"27","author":"Uchida","year":"2019","journal-title":"Mol Ther"},{"issue":"17","key":"2026041408021560700_bib17","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJM199310213291702","article-title":"Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support","volume":"329","author":"Press","year":"1993","journal-title":"N Engl J Med"},{"issue":"7","key":"2026041408021560700_bib18","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1182\/blood-2003-02-0622","article-title":"High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis","volume":"102","author":"Gopal","year":"2003","journal-title":"Blood"},{"issue":"9","key":"2026041408021560700_bib19","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.bbmt.2014.05.014","article-title":"Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndrome","volume":"20","author":"Mawad","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2026041408021560700_bib20","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1158\/2159-8290.CD-24-0708","article-title":"The journey of antibody-drug conjugates: lessons learned from 40 years of development","volume":"14","author":"Colombo","year":"2024","journal-title":"Cancer Discov"},{"issue":"21","key":"2026041408021560700_bib21","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1182\/blood.2023023549","article-title":"Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate-conditioned Fanconi anemia mice","volume":"143","author":"Saha","year":"2024","journal-title":"Blood"},{"issue":"11","key":"2026041408021560700_bib22","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1182\/blood.2021012366","article-title":"A CD45-targeted antibody-drug conjugate successfully conditions for allogeneic hematopoietic stem cell transplantation in mice","volume":"139","author":"Saha","year":"2022","journal-title":"Blood"},{"issue":"7","key":"2026041408021560700_bib23","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nbt.3584","article-title":"Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin","volume":"34","author":"Palchaudhuri","year":"2016","journal-title":"Nat Biotechnol"},{"issue":"6","key":"2026041408021560700_bib24","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.ymthe.2024.03.032","article-title":"Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant","volume":"32","author":"Yeung","year":"2024","journal-title":"Mol Ther"},{"issue":"1","key":"2026041408021560700_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1021\/acs.bioconjchem.9b00777","article-title":"Site-specific conjugation of the indolinobenzodiazepine DGN549 to antibodies affords antibody-drug conjugates with an improved therapeutic index as compared with lysine conjugation","volume":"31","author":"Bai","year":"2020","journal-title":"Bioconjug Chem"},{"issue":"10","key":"2026041408021560700_bib26","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1158\/1535-7163.MCT-19-1102","article-title":"Preclinical antitumor activity and biodistribution of a novel anti-GCC antibody-drug conjugate in patient-derived xenografts","volume":"19","author":"Abu-Yousif","year":"2020","journal-title":"Mol Cancer Ther"},{"key":"2026041408021560700_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ddtec.2018.08.005","article-title":"Amanitins and their development as a payload for antibody-drug conjugates","volume":"30","author":"Pahl","year":"2018","journal-title":"Drug Discov Today Technol"},{"issue":"suppl 1","key":"2026041408021560700_bib28","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood-2021-153074","article-title":"JSP191 as a single-agent conditioning regimen results in successful engraftment, donor myeloid chimerism, and production of donor derived na\u00efve lymphocytes in patients with severe combined immunodeficiency (SCID)","volume":"138","author":"Agarwal","year":"2021","journal-title":"Blood"},{"key":"2026041408021560700_bib29","author":"Taylor","year":"2023"},{"key":"2026041408021560700_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im22a01s69","article-title":"Large animal models for stem and progenitor cell analysis","author":"Donahue","year":"2005","journal-title":"Curr Protoc Immunol"},{"issue":"6","key":"2026041408021560700_bib31","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1089\/104303401300057289","article-title":"Update on the use of nonhuman primate models for preclinical testing of gene therapy approaches targeting hematopoietic cells","volume":"12","author":"Donahue","year":"2001","journal-title":"Hum Gene Ther"},{"issue":"6","key":"2026041408021560700_bib32","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood-2007-02-075382","article-title":"Hematopoietic stem-cell behavior in nonhuman primates","volume":"110","author":"Shepherd","year":"2007","journal-title":"Blood"},{"issue":"1","key":"2026041408021560700_bib33","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1038\/s41467-023-41153-5","article-title":"Fertility-preserving myeloablative conditioning using single-dose CD117 antibody-drug conjugate in a rhesus gene therapy model","volume":"14","author":"Uchida","year":"2023","journal-title":"Nat Commun"},{"issue":"2","key":"2026041408021560700_bib34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.stem.2024.10.014","article-title":"BCL11A +58\/+55 enhancer-editing facilitates HSPC engraftment and HbF induction in rhesus macaques conditioned with a CD45 antibody-drug conjugate","volume":"32","author":"Demirci","year":"2025","journal-title":"Cell Stem Cell"},{"issue":"10","key":"2026041408021560700_bib35","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nbt.1977","article-title":"Tracking single hematopoietic stem cells in vivo using high-throughput sequencing in conjunction with viral genetic barcoding","volume":"29","author":"Lu","year":"2011","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2026041408021560700_bib36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.stem.2014.01.020","article-title":"Clonal tracking of rhesus macaque hematopoiesis highlights a distinct lineage origin for natural killer cells","volume":"14","author":"Wu","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"19","key":"2026041408021560700_bib37","doi-asserted-by":"crossref","first-page":"9854","DOI":"10.1128\/JVI.00357-09","article-title":"Development of a human immunodeficiency virus type 1-based lentiviral vector that allows efficient transduction of both human and rhesus blood cells","volume":"83","author":"Uchida","year":"2009","journal-title":"J Virol"},{"issue":"6","key":"2026041408021560700_bib38","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cell.2018.05.013","article-title":"Genetic inactivation of CD33 in hematopoietic stem cells to enable CAR T cell immunotherapy for acute myeloid leukemia","volume":"173","author":"Kim","year":"2018","journal-title":"Cell"},{"issue":"5","key":"2026041408021560700_bib39","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.stem.2024.04.005","article-title":"Impact of CRISPR\/HDR editing versus lentiviral transduction on long-term engraftment and clonal dynamics of HSPCs in rhesus macaques","volume":"31","author":"Lee","year":"2024","journal-title":"Cell Stem Cell"},{"key":"2026041408021560700_bib40","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.3389\/fimmu.2019.02381","article-title":"Impact of CMV infection on natural killer cell clonal repertoire in CMV-naive rhesus macaques","volume":"10","author":"Truitt","year":"2019","journal-title":"Front Immunol"},{"issue":"29","key":"2026041408021560700_bib41","doi-asserted-by":"crossref","first-page":"eaat9781","DOI":"10.1126\/sciimmunol.aat9781","article-title":"Clonal expansion and compartmentalized maintenance of rhesus macaque NK cell subsets","volume":"3","author":"Wu","year":"2018","journal-title":"Sci Immunol"},{"key":"2026041408021560700_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.omtm.2018.10.009","article-title":"Barcoding of macaque hematopoietic stem and progenitor cells: a robust platform to assess vector genotoxicity","volume":"11","author":"Yabe","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"4","key":"2026041408021560700_bib43","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s43588-021-00057-4","article-title":"Interrogation of clonal tracking data using barcodetrackR","volume":"1","author":"Espinoza","year":"2021","journal-title":"Nat Comput Sci"},{"issue":"7","key":"2026041408021560700_bib44","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/all.16434","article-title":"Multiomic integration analysis for monitoring severe asthma treated with mepolizumab or omalizumab","volume":"80","author":"Contreras","year":"2025","journal-title":"Allergy"},{"key":"2026041408021560700_bib45","doi-asserted-by":"crossref","first-page":"100168","DOI":"10.1016\/j.mcpro.2021.100168","article-title":"Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis","volume":"20","author":"Wik","year":"2021","journal-title":"Mol Cell Proteomics"},{"issue":"16","key":"2026041408021560700_bib46","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1182\/blood.2021014875","article-title":"A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions","volume":"140","author":"Shin","year":"2022","journal-title":"Blood"},{"issue":"2","key":"2026041408021560700_bib47","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/gt.2013.67","article-title":"Evaluation of engraftment and immunological tolerance after reduced intensity conditioning in a rhesus hematopoietic stem cell gene therapy model","volume":"21","author":"Uchida","year":"2014","journal-title":"Gene Ther"},{"issue":"24","key":"2026041408021560700_bib48","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1182\/blood-2015-07-657346","article-title":"Discordance in lymphoid tissue recovery following stem cell transplantation in rhesus macaques: an in vivo imaging study","volume":"126","author":"Donahue","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2026041408021560700_bib49","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1084\/jem.20171341","article-title":"Geographic clonal tracking in macaques provides insights into HSPC migration and differentiation","volume":"215","author":"Wu","year":"2018","journal-title":"J Exp Med"},{"issue":"6","key":"2026041408021560700_bib50","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1111\/bjh.19889","article-title":"Long-term tracking of haematopoietic clonal dynamics and mutations in non-human primate undergoing transplantation of lentivirally barcoded haematopoietic stem and progenitor cells","volume":"205","author":"Hosuru","year":"2024","journal-title":"Br J Haematol"},{"issue":"11","key":"2026041408021560700_bib51","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1182\/blood-2016-07-728691","article-title":"Quantitative stability of hematopoietic stem and progenitor cell clonal output in rhesus macaques receiving transplants","volume":"129","author":"Koelle","year":"2017","journal-title":"Blood"},{"issue":"24","key":"2026041408021560700_bib52","doi-asserted-by":"crossref","first-page":"e145501","DOI":"10.1172\/JCI145501","article-title":"Antibody-drug conjugates plus Janus kinase inhibitors enable MHC-mismatched allogeneic hematopoietic stem cell transplantation","volume":"131","author":"Persaud","year":"2021","journal-title":"J Clin Invest"},{"key":"2026041408021560700_bib53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.imlet.2018.01.009","article-title":"CD45 in human physiology and clinical medicine","volume":"196","author":"Rheinlander","year":"2018","journal-title":"Immunol Lett"},{"issue":"31","key":"2026041408021560700_bib54","doi-asserted-by":"crossref","first-page":"eabh2169","DOI":"10.1126\/sciadv.abh2169","article-title":"A single-cell type transcriptomics map of human tissues","volume":"7","author":"Karlsson","year":"2021","journal-title":"Sci Adv"},{"key":"2026041408021560700_bib55","author":"The Human Protein Atlas","year":"2024"},{"issue":"6472","key":"2026041408021560700_bib56","doi-asserted-by":"crossref","first-page":"eaax9198","DOI":"10.1126\/science.aax9198","article-title":"A genome-wide transcriptomic analysis of protein-coding genes in human blood cells","volume":"366","author":"Uhlen","year":"2019","journal-title":"Science"},{"issue":"576","key":"2026041408021560700_bib57","doi-asserted-by":"crossref","first-page":"eabb4582","DOI":"10.1126\/scitranslmed.abb4582","article-title":"Measurement of leukocyte trafficking kinetics in macaques by serial intravascular staining","volume":"13","author":"Potter","year":"2021","journal-title":"Sci Transl Med"},{"issue":"11","key":"2026041408021560700_bib58","doi-asserted-by":"crossref","first-page":"1104.e1-e14","DOI":"10.1016\/j.jtct.2024.09.008","article-title":"Levels of C-reactive protein and body temperature elevation during neutropenia predict engraftment and non-relapse mortality for unrelated single-unit cord blood transplantation in adults","volume":"30","author":"Konuma","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"2026041408021560700_bib59","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.stemcr.2022.05.021","article-title":"Neutrophils as regulators of macrophage-induced inflammation in a setting of allogeneic bone marrow transplantation","volume":"17","author":"Hong","year":"2022","journal-title":"Stem Cell Rep"},{"issue":"4","key":"2026041408021560700_bib60","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1128\/iai.57.4.1218-1226.1989","article-title":"Tumor necrosis factor alpha-induced pulmonary vascular endothelial injury","volume":"57","author":"Goldblum","year":"1989","journal-title":"Infect Immun"},{"issue":"5","key":"2026041408021560700_bib61","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3390\/ijms19051269","article-title":"VEGF (vascular endothelial growth factor) and fibrotic lung disease","volume":"19","author":"Barratt","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"18","key":"2026041408021560700_bib62","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/0008-5472.CAN-09-0577","article-title":"Matrix metalloproteinase 12 overexpression in lung epithelial cells plays a key role in emphysema to lung bronchioalveolar adenocarcinoma transition","volume":"69","author":"Qu","year":"2009","journal-title":"Cancer Res"},{"issue":"4","key":"2026041408021560700_bib63","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"issue":"12","key":"2026041408021560700_bib64","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ni.2156","article-title":"IL-17C regulates the innate immune function of epithelial cells in an autocrine manner","volume":"12","author":"Ramirez-Carrozzi","year":"2011","journal-title":"Nat Immunol"},{"issue":"4","key":"2026041408021560700_bib65","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1182\/blood.V94.4.1237","article-title":"Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome","volume":"94","author":"Matthews","year":"1999","journal-title":"Blood"},{"issue":"1","key":"2026041408021560700_bib66","doi-asserted-by":"crossref","first-page":"e70063","DOI":"10.1002\/hem3.70063","article-title":"The CD123 antibody-drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemia","volume":"9","author":"Watts","year":"2025","journal-title":"Hemasphere"},{"issue":"3","key":"2026041408021560700_bib67","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1470-2045(23)00674-5","article-title":"Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody\u2013drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1\/2 study","volume":"25","author":"Daver","year":"2024","journal-title":"Lancet Oncol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/7\/2479\/2512767\/blooda_adv-2025-018176-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/7\/2479\/2512767\/blooda_adv-2025-018176-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:02:29Z","timestamp":1776168149000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/7\/2479\/566267\/Clonal-dynamics-tolerance-and-adverse-events-after"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018176","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,14]]},"published":{"date-parts":[[2026,4,6]]}}}